| Old Articles: <Older 6371-6380 Newer> |
|---|
 |
The Motley Fool
March 18, 2005
Selena Maranjian |
More Genius Stock Ideas Six stocks that look poised to do well in the future: Medtronic... Paychex... PepsiCo... Procter & Gamble... Sysco... Wrigley...   |
The Motley Fool
March 18, 2005
Rick Aristotle Munarriz |
That's Incredibles Disney, Pixar, DreamWorks, and even Fox, now that it topped the box office this past weekend with Robots, all deserve investor interest for their recent and future animated projects. |
The Motley Fool
March 18, 2005
Rick Aristotle Munarriz |
Kellogg Shelves Elves The cereal and snack maker looks to scale back in order to move forward. Closing some of its plants may improve the company's margins slightly, but it would need a lot more than elfin disappearing magic to justify the stock's current lofty premiums. |
The Motley Fool
March 18, 2005
Selena Maranjian |
Invest Like a Woman Are there really any differences between men and women when it comes to investing? Many women invest cautiously, often with better results. |
The Motley Fool
March 17, 2005
Tim Beyers |
Profit by Seeing Green Companies that trade for close to what they have per-share in the bank can make for promising investments, like Boston Communications... RTW Inc... GSI Lumonics... |
The Motley Fool
March 17, 2005
W.D. Crotty |
RVs: Supply and Demand Winnebago reports a down quarter and cites rising industry inventories. Investors, beware. |
InternetNews
March 17, 2005
Roy Mark |
SAP Boosts Offer For Retek New $629 million bid counters Oracle's $525 million offer for retail software and services firm. |
InternetNews
March 17, 2005
Jim Wagner |
Qwest Meets Deadline, Increases MCI Offer Qwest met its St. Patrick's Day deadline and raised its bid for MCI nearly $500 million, increasing the value of the acquisition to $26 per share. |
The Motley Fool
March 17, 2005
Steven Mallas |
Pepsi Gets Two Thumbs Up PepsiCo will continue its long association with the National Amusements theater chain. Investors, take note. |
The Motley Fool
March 17, 2005
Tom Taulli |
Bitter Pill for ProxyMed Technology was supposed to make health care cheaper and tech companies richer. Neither seems to be the case. While ProxyMed has dealt with its regulatory costs and is continuing to see growth in its business, there are many questions lingering for investors. |
| <Older 6371-6380 Newer> Return to current articles. |
